SCHEMBL6876573

SCHEMBL6876573

COc1cc(CC(=O)N[C@H]2CC[C@@H](Nc3nccc(N(C)C)n3)CC2)cc(OC)c1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AURKB Q96GD4 2/20 0.54
CNR1 P21554 2/20 0.54
KCNH2 Q12809 1/20 0.54
MCHR1 Q99705 10/20 0.48
SIGMAR1 Q99720 2/20 0.48
ADRA2A P08913 3/20 0.46
AURKA O14965 1/20 0.44
CNR2 P34972 1/20 0.43
EPHX2 P34913 1/20 0.43
HRH1 P35367 2/20 0.41
HTR2B P41595 2/20 0.41
ADRA1A P35348 1/20 0.41
CYP3A4 P08684 2/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C19 P33261 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6876586 1.00 AURKB (0.54) AURKBCNR1KCNH2MCHR1SIGMAR1
SCHEMBL6869319 0.91 MCHR1 (0.55) AURKBCNR1KCNH2MCHR1SIGMAR1
SCHEMBL6869316 0.91 MCHR1 (0.55) AURKBCNR1KCNH2MCHR1SIGMAR1
SCHEMBL6869407 0.91 EPHX2 (0.55) AURKBCNR1KCNH2MCHR1SIGMAR1
SCHEMBL6869412 0.91 EPHX2 (0.55) AURKBCNR1KCNH2MCHR1SIGMAR1
SCHEMBL6875725 0.88 AURKB (0.43) AURKBCNR1KCNH2MCHR1SIGMAR1
SCHEMBL6875736 0.88 AURKB (0.43) AURKBCNR1KCNH2MCHR1SIGMAR1
SCHEMBL6874375 0.86 SIGMAR1 (0.49) AURKBCNR1KCNH2MCHR1SIGMAR1
SCHEMBL6874385 0.86 SIGMAR1 (0.49) AURKBCNR1KCNH2MCHR1SIGMAR1
SCHEMBL6458663 0.86 CNR1 (0.73) AURKBCNR1KCNH2MCHR1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1464335-A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist Taisho Pharmaceutical Co. Ltd. (JP) 2004-10-06 EP disclosed